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Each month, Chemistry & Biology Select highlights a selection of research reports from the recent
literature. These highlights are a snapshot of interesting research done across the field of chemical
biology. This installment was scheduled to be published in the March 2015 issue; however, unfore-
seen circumstances caused a delay in publication. Nevertheless, we think that you will enjoy
reading about the research despite the delay. Our March 2015 selection includes reports on the
potential new role for bile acids, dual-pharmacophore encoded self-assembling chemical libraries,
how to control the Ebola virus, and how bacteria use uracil to control the host.
Bile Acids as Enzyme Regulators
Fatty acid ethanolamides (FAEs) are a diverse group of lipid molecules that control a large number of physiological processes,
such as satiety and body weight, cancer cell proliferation, inflammation, and stress and pain responses. The final step of
FAEs biosynthesis involves a membrane enzyme, N-acylphosphatidylethanolamines (NAPE)-hydrolyzing phospholipase
D (NAPE-PLD). As the name suggests, NAPE-PLD uses various NAPEs as substrates and converts them into FAEs. The
process is accompanied by the release of phosphatidic acid (PA). In order to gain a better insight into human NAPE-PLD
function, and the biosynthesis of FAEs in general, Magotti et al. decided to start by solving the structure of this enzyme.
Crystallization of membrane proteins is a significant challenge, and in the case of NAPE-PLD, obtaining the high-quality
crystals needed for structural analysis required the use of the detergent sodium deoxycholate (DC), a bile acid. The final
structure of human NAPE-PLD was solved at 2.65 A˚ resolution, and the authors describe several interesting features of
this enzyme; for example, NAPE-PLD forms a dimer in which the two subunits are separated by an internal channel that
measures 9 A˚ in diameter! Additionally, the dimer forms a hydrophobic nook at themembrane interface, and the nook swarms
with features of interest. It includes two molecules of phosphatidylethanolamine (PE) that originated from the membranes of
E. coli, the heterologous host used to overproduce NAPE-PLD. Interestingly, PE molecules assume a position that seems to
mimic substrate binding, revealing likely reasons why NAPE-PLD can accommodate a wide range of substrates. The most
surprising features of the hydrophobic nook by far are the four bile-acid DC molecules that Magotti et al. observe bound in
the nook. The authors complement their structural work with some functional analysis, and based on combined observations,
they propose that the interaction between NAPE-PLD and bile acids is likely physiologically relevant. This insight bringsWichert et al. develop a
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Magotti et al. (2015). Structure 23, 598–604. http://dx.doi.org/10.1016/j.str.2014.12.018
Two Birds with One Stone
Most drugs are smallmolecules butmost smallmolecules are unlikely to bedrugs. Therefore, it is
nowonder thatmanycurrent researchefforts indrugdiscovery focusondevelopingmethods that
can rapidly separate the wheat from the chaff.
One strategy uses DNA-encoded chemical libraries (DECLs), in which small molecules are
conjugated to DNA fragments. These DNA fragments have a dual purpose: they provide
each small molecule with a unique DNA identifier and they enable amplification and enrichment
of the DNA barcodes and allow the identification of hit compound(s). This means that DECLs
can be enormous; the largest hasmore than 4 billion compounds, thus increasing the likelihood
of finding a small molecule with desired high affinity.
Another strategy is fragment-based drug discovery (FBDD). In FBDD, the focus is on finding
small chemical fragments with low affinity for their targets that can be then joined with other
fragments into compounds with increased affinity. This creates opportunities for targeting pro-
tein-protein interactions or proteins with shallow binding pockets.
Wichert et al. now put the two strategies together and develop a dual-pharmacophore en-
coded self-assembling chemical (ESAC) library, in which two small molecules are conjugated
to the ends of complementary DNA strands, one to the 50end of one strand (compound A) and
the other to the 30end of the other strand (compound B). The dual-pharmacophore library was
assembled from 550 A and 202 B encoded pharmacophores, yielding a combinatorial library of
111,100 compounds. Here, Wichert et al. use a neat trick: they apply a Klenow-polymerase to
transfer B coding sequences onto the corresponding A strand by a fill-in reaction. Thus, eachChemistry & Biology 22, April 23, 2015 ª2015 Elsevier Ltd All rights reserved 427
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validating their technology, Wichert et al. employ it to orosomucoid (ORM) and carbonic anhydrase IX (CAIX). In the case of
ORM, this leads to to the de novo discovery of a low mM inhibitor and, in the case of CAIX, to the optimization of a known
inhibitor, acetazolamide (AAZ), which resulted in a compoundwith a promising anticancer activity profile. The new technology
thus enables simultaneous, efficient selection of ligand pairs and offers a platform for future expansion of ligand diversity by
linear expansion of the sublibraries.
Wichert et al. (2015). Nat. Chem. 7, 241–249. http://dx.doi.org/10.1038/NCHEM.2158The image is from a 3D
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According to Google Trends, worldwide search for ‘‘Ebola’’ peaked between October 12 and
18, 2014. At that point, the first case of Ebola in the United States was confirmed, sending
both the media and the public into a frenzy. The latest, and still on-going, Ebola virus (EBOV)
outbreak inWest Africa has killedmore than ten thousand people, devastated local economies,
and showed how quickly the virus can spread and how far it can travel in our interconnected
world. It also highlighted how unprepared we are to respond to EBOV and how urgently we
need viable treatment options.
There are many ways in which one can target a virus like EBOV. For example, during
different stages of its lifecycle, EBOV hijacks many proteins and pathways of the host cell.
This makes targeting a host protein an attractive strategy in antiviral drug development.
Results from the recent work by Sakurai et al. suggest that this approach might work well
for preventing EBOV infection. The authors build on previous observations that EBOV enters
the host cell via trafficking through endosomal vesicles and that host calcium signaling
proteins are important for this process. Sakurai et al. probe the molecular basis for these
observations and discover that two-pore channels (TPCs), calcium channels regulated by
nicotinic acid adenine dinucleotide phosphate (NAADP), control trafficking of EBOV-loaded
endosomes, and thus viral entry into the host cell. Additionally, Sakurai et al. show that inhi-
bition of TPCs by a small molecule antagonist, tetrandrine, prevents EBOV infection in human
macrophages and in the mouse model. The work accentuates the importance of building
better understanding of the molecular basis of EBOV infection and the host-centric road
to anti-EBOV drug development.
Sakurai et al. (2015). Science 347, 995–998. http://dx.doi.org/10.1126/science.1258758The image shows the effect
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courtesy of Kyung-Ah Lee.It All Comes Down to Uracil
Although small in size, the common fruit fly, Drosophila melanogaster, as one of the most
frequently used model organisms, is the giant of biomedical research. This giant of model or-
ganisms has one more item to add to its impressive resume: the use in studies of gut-microbe
interactions. Previous work on Drosophila gut-microbiota homeostasis established a role for
dual oxidase (DUOX) that leads to production of reactive oxygen species (ROS) as one line
of defense against opportunistic pathogens in the gut. Another line of defense, the immune
deficiency (IMD) pathway, produces antimicrobial peptides (AMPs).
AlthoughROS and AMPswork together to keep the gutmicrobes in check, the two pathways
that produce them respond to different bacterial cues. The trigger for the IMD pathway is a
specific type of bacterial peptidoglycans (PG). The trigger for DUOX is bacterial uracil. How
does uracil do this? Lee et al. provide an answer to this question. The authors present
evidence that uracil activates the Hedgehog (Hh) signaling pathway of the fly midgut epithelia
and that this leads to activation of DUOX and ROS generation. One of the key players in
this process is cadherin 99C (Cad99C), as Hh signaling activation results in formation of
Cad99C-dependent signaling endosomes. Without the ability to produce enough Cad99C
and form endosomes, the flies succumb to the pathogen infection. Overall, Lee et al. offer
an interesting view of what happens in Drosophila gut when bacterial uracil is present. Two
important remaining questions that Lee et al. highlight are the identity of the receptor(s) for
uracil and the exact mechanism that links Cad99C and DUOX. These are the challenge for
the next set of experiments, and the work by Lee et al. forms a solid foundation on which to
build.
Lee et al. (2015). Cell HostMicrobe 17, 191–204. http://dx.doi.org/10.1016/j.chom.2014.12.012
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